indole has been researched along with Brain Neoplasms in 2 studies
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sherer, C | 1 |
| Tolaymat, I | 1 |
| Rowther, F | 1 |
| Warr, T | 1 |
| Snape, TJ | 1 |
| Nguyen, P | 1 |
| Doan, P | 1 |
| Rimpilainen, T | 1 |
| Konda Mani, S | 1 |
| Murugesan, A | 1 |
| Yli-Harja, O | 1 |
| Candeias, NR | 1 |
| Kandhavelu, M | 1 |
2 other studies available for indole and Brain Neoplasms
| Article | Year |
|---|---|
Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening | 2017 |
Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationshi | 2021 |